Search results for "Urinary tract infections"
New report proposes solutions to drug shortages
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/01/new-report-proposes-solutions-to-drug-shortages.htm
1 Jan 2020
Warnings on testosterone, new antibiotic approved
This update covers a label change on testosterone products clarifying that they are approved only for men who have low testosterone levels, as well as the approval of ceftazidime-avibactam (Avycaz) to treat complicated intra-abdominal infections.
https://immattersacp.org/archives/2015/05/fda.htm
1 May 2015
Anticholinergic therapy and onabotulinumtoxinA appear equally effective for urgency urinary incontinence
Oral anticholinergic therapy and injection onabotulinumtoxinA appear to be equally effective for treating urgency urinary incontinence, according to a new trial.
https://immattersacp.org/weekly/archives/2012/10/16/4.htm
16 Oct 2012
New heart disease test, drugs for flu, weight management
This update covers a new test to predict risk of future coronary heart disease events, the first neuraminidase inhibitor for influenza, and a new GLP-1 agonist for obese people.
https://immattersacp.org/archives/2015/03/fda.htm
1 Mar 2015
Rare but resistant and deadly strains of Enterobacteriaceae increasing
Rare but deadly strains of carbapenem-resistant Enterobacteriaceae (CRE) are on the rise, stated a report.
https://immattersacp.org/weekly/archives/2013/03/12/5.htm
12 Mar 2013
New diabetes drug, LABA for COPD, skin antibiotic approved
This update covers approval of a sodium-glucose co-transporter 2 inhibitor for diabetes, a once-daily long-acting beta-adrenergic agonist (LABA) for chronic obstructive pulmonary disease (COPD), and a new intravenous drug for bacterial skin and skin-structure infections.
https://immattersacp.org/archives/2014/10/fda.htm
1 Oct 2014
Study analyzes diagnostic errors in primary care
Diagnostic errors in primary care are often related to process breakdowns during the clinical encounter, according to a new study.
https://immattersacp.org/weekly/archives/2013/03/05/4.htm
5 Mar 2013
FDA issues alert for CellCept, recalls for Solodyn, Digitek
An overview of agency actions, including an alert for CellCept and recalls for Solodyn and Digitek.
https://immattersacp.org/archives/2008/07/fda.htm
1 Jul 2008
New drugs approved for type 2 diabetes and COPD
This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease.
https://immattersacp.org/archives/2014/03/fda.htm
1 Mar 2014
Doripenem not for pneumonia; migraine device approved
This update covers a labeling change for doripenem (Doribax) and a warning about risk of death for ventilator patients with pneumonia, among other regulatory actions.
https://immattersacp.org/archives/2014/05/fda.htm
1 May 2014